市場調査レポート

商品コード

1446409

アルブミン市場：タイプ別、用途別、販売チャネル別：世界の機会分析と産業予測、2023-2032年

Albumin Market By Type, By Application, By Sales Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2024年01月30日 | 発行: Allied Market Research

| ページ情報: 英文 287 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,570 560,989円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,730 900,412円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,508,544円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

さらに、アルブミン市場の成長は、製品の発売、買収、契約など、主要な業界企業の間で重要な戦略の実施が増加していることによって推進されています。

例えば、2020年9月、ライフサイエンス研究とバイオ医薬品業界の国際的な主要パートナーであるSartorius Groupは、組み換えアルブミンベースのソリューション分野のリーダーであるAlbumedix Ltdの買収を発表しました。さらに、血漿由来医薬品の世界的大手メーカーであるグリフォルス社は、アルブミンポートフォリオの最新イノベーションであるALBUTEIN FlexBagの5％および25％濃度の発売を発表しました。このような戦略的な動きは、イノベーションを推進するだけでなく、ヘルスケアおよびバイオ医薬品業界の進化するニーズに対応することで、市場の成長を促進します。

加えて、技術的進歩もアルブミン市場成長の主な促進要因となっています。製薬・バイオテクノロジー分野では、生産プロセスや精製技術における絶え間ない技術革新がアルブミン製品の効率と品質を高めています。先端技術はまた、新規のアルブミンベースの製剤の開発にも貢献し、ドラッグデリバリーシステムや診断への応用を拡大しています。製造、精製、分析における精度の高さは、不純物を最小限に抑えた高品質のアルブミンを保証し、厳しい規制基準を満たしています。さらに、技術の進歩はアルブミン製造のための代替供給源の探求を容易にし、サプライチェーンの課題に対処します。技術とアルブミン生産の相乗効果は、既存製品を改善するだけでなく、最先端のソリューションの創出を促進し、アルブミン市場の全体的な拡大に拍車をかけています。

アルブミン市場は、タイプ、用途、販売チャネル、地域によって区分されます。タイプ別では、ヒト血清アルブミン、ウシ血清アルブミン、遺伝子組換えアルブミンに分類されます。用途別では、治療薬、製剤・ワクチン、培地成分、その他に分類されます。販売チャネル別では、企業間取引（B2B）と消費者間取引（B2C）に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州地域）、アジア太平洋地域（日本、中国、インド、オーストラリア、韓国、その他アジア太平洋地域）、アジア太平洋地域（ブラジル、中国、アラビア、その他アジア太平洋地域）で分析されます。

利害関係者にとっての主なメリット

当レポートでは、2022年から2032年までのアルブミン市場分析の市場セグメント、現在の動向、推定・動向分析、ダイナミクスを定量的に分析し、アルブミン市場の有力な機会を特定します。
市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるように、バイヤーとサプライヤーの潜在力を強調します。
アルブミン市場のセグメンテーションの詳細な分析は、市場機会を決定するのに役立ちます。
各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
市場企業のポジショニングは、ベンチマーキングを容易にし、市場企業の現在のポジションの明確な理解を提供します。
本レポートは、地域および世界のアルブミン市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

本レポートで可能なレポートカスタマイズ（追加費用とスケジュールがあります。）

国、地域、世界レベルでの患者/疫学データ
規制ガイドライン
クライアントの関心に特化した追加企業プロファイル
企業プロファイルの拡張リスト
過去の市場データ
償還シナリオ
SWOT分析

市場の定義と範囲
主な調査結果
- 影響要因
- 主な投資機会
ポーターのファイブフォース分析
市場力学
- 促進要因
  - 手術件数の増加
  - 献血に対する意識の高まり
  - 医薬品開発における血漿由来アルブミン使用の増加
- 抑制要因
  - 厳しい政府規制
- 機会
  - 新興市場における成長機会

第4章アルブミン市場：タイプ別

概要
ヒト血清アルブミン
牛血清アルブミン
遺伝子組み換えアルブミン

第5章アルブミン市場：用途別

概要
治療薬
医薬品製剤とワクチン
培地成分
その他

第6章アルブミン市場：販売チャネル別

概要
B2C
B2B
- B2Bアルブミン市場：タイプ別
  - 医薬品用途アルブミン市場：タイプ別
  - 非医薬用途アルブミン市場：タイプ別

第7章アルブミン市場、地域別

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他
ラテンアメリカ・中東・アフリカ
- ブラジル
- サウジアラビア
- 南アフリカ
- その他

第8章競争情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング、2022年

第9章企業プロファイル

Merck KGaA
Sartorius AG
Octapharma AG
Thermo Fisher Scientific Inc.
Ventria Bioscience Inc.
Grifols, S.A.
CSL
China Biologic Products Holdings, Inc
Lazuline Bio
Takeda Pharmaceutical Company Limited

図表

LIST OF TABLES

TABLE 01. GLOBAL ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. ALBUMIN MARKET FOR HUMAN SERUM ALBUMIN, BY REGION, 2022-2032 ($MILLION)
TABLE 03. ALBUMIN MARKET FOR BOVINE SERUM ALBUMIN, BY REGION, 2022-2032 ($MILLION)
TABLE 04. ALBUMIN MARKET FOR RECOMBINANT ALBUMIN, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 06. ALBUMIN MARKET FOR THERAPEUTICS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. ALBUMIN MARKET FOR DRUG FORMULATION AND VACCINES, BY REGION, 2022-2032 ($MILLION)
TABLE 08. ALBUMIN MARKET FOR COMPONENT OF MEDIA, BY REGION, 2022-2032 ($MILLION)
TABLE 09. ALBUMIN MARKET FOR OTHER, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 11. ALBUMIN MARKET FOR B2C, BY REGION, 2022-2032 ($MILLION)
TABLE 12. ALBUMIN MARKET FOR B2B, BY REGION, 2022-2032 ($MILLION)
TABLE 13. GLOBAL B2B ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL APPLICATIONS ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 15. GLOBAL NON PHARMACEUTICAL APPLICATIONS ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 16. ALBUMIN MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 21. U.S. ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 22. U.S. ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 23. U.S. ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 24. CANADA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 25. CANADA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 26. CANADA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 27. MEXICO ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 28. MEXICO ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 29. MEXICO ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 30. EUROPE ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. EUROPE ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 32. EUROPE ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 33. EUROPE ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 34. GERMANY ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 35. GERMANY ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 36. GERMANY ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 37. FRANCE ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 38. FRANCE ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. FRANCE ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 40. UK ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 41. UK ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 42. UK ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 43. ITALY ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 44. ITALY ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. ITALY ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 46. SPAIN ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 47. SPAIN ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 48. SPAIN ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 51. REST OF EUROPE ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 55. ASIA-PACIFIC ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 56. JAPAN ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 57. JAPAN ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. JAPAN ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 59. CHINA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 60. CHINA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 61. CHINA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 62. INDIA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 63. INDIA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 64. INDIA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 66. AUSTRALIA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 67. AUSTRALIA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. SOUTH KOREA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 74. LAMEA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 75. LAMEA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. LAMEA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 77. LAMEA ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 78. BRAZIL ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 79. BRAZIL ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 80. BRAZIL ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. SAUDI ARABIA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 86. SOUTH AFRICA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 89. REST OF LAMEA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
TABLE 90. MERCK KGAA: KEY EXECUTIVES
TABLE 91. MERCK KGAA: COMPANY SNAPSHOT
TABLE 92. MERCK KGAA: PRODUCT SEGMENTS
TABLE 93. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 94. SARTORIUS AG: KEY EXECUTIVES
TABLE 95. SARTORIUS AG: COMPANY SNAPSHOT
TABLE 96. SARTORIUS AG: PRODUCT SEGMENTS
TABLE 97. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 98. SARTORIUS AG: KEY STRATERGIES
TABLE 99. OCTAPHARMA AG: KEY EXECUTIVES
TABLE 100. OCTAPHARMA AG: COMPANY SNAPSHOT
TABLE 101. OCTAPHARMA AG: PRODUCT SEGMENTS
TABLE 102. OCTAPHARMA AG: PRODUCT PORTFOLIO
TABLE 103. OCTAPHARMA AG: KEY STRATERGIES
TABLE 104. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
TABLE 105. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
TABLE 106. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
TABLE 107. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
TABLE 108. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
TABLE 109. VENTRIA BIOSCIENCE INC.: KEY EXECUTIVES
TABLE 110. VENTRIA BIOSCIENCE INC.: COMPANY SNAPSHOT
TABLE 111. VENTRIA BIOSCIENCE INC.: PRODUCT SEGMENTS
TABLE 112. VENTRIA BIOSCIENCE INC.: PRODUCT PORTFOLIO
TABLE 113. GRIFOLS, S.A.: KEY EXECUTIVES
TABLE 114. GRIFOLS, S.A.: COMPANY SNAPSHOT
TABLE 115. GRIFOLS, S.A.: PRODUCT SEGMENTS
TABLE 116. GRIFOLS, S.A.: PRODUCT PORTFOLIO
TABLE 117. GRIFOLS, S.A.: KEY STRATERGIES
TABLE 118. CSL: KEY EXECUTIVES
TABLE 119. CSL: COMPANY SNAPSHOT
TABLE 120. CSL: PRODUCT SEGMENTS
TABLE 121. CSL: PRODUCT PORTFOLIO
TABLE 122. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: KEY EXECUTIVES
TABLE 123. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: COMPANY SNAPSHOT
TABLE 124. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: PRODUCT SEGMENTS
TABLE 125. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: PRODUCT PORTFOLIO
TABLE 126. LAZULINE BIO: KEY EXECUTIVES
TABLE 127. LAZULINE BIO: COMPANY SNAPSHOT
TABLE 128. LAZULINE BIO: PRODUCT SEGMENTS
TABLE 129. LAZULINE BIO: PRODUCT PORTFOLIO
TABLE 130. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY EXECUTIVES
TABLE 131. TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT
TABLE 132. TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT SEGMENTS
TABLE 133. TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT PORTFOLIO
TABLE 134. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY STRATERGIES

LIST OF FIGURES

FIGURE 01. ALBUMIN MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF ALBUMIN MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN ALBUMIN MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN ALBUMIN MARKET (2023-2032)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL ALBUMIN MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. ALBUMIN MARKET, BY TYPE, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR HUMAN SERUM ALBUMIN, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR BOVINE SERUM ALBUMIN, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR RECOMBINANT ALBUMIN, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. ALBUMIN MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR THERAPEUTICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR DRUG FORMULATION AND VACCINES, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR COMPONENT OF MEDIA, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR OTHER, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. ALBUMIN MARKET, BY SALES CHANNEL, 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR B2C, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR B2B, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. ALBUMIN MARKET BY REGION, 2022 AND 2032(%)
FIGURE 24. U.S. ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 25. CANADA ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 26. MEXICO ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 27. GERMANY ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 28. FRANCE ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 29. UK ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 30. ITALY ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 31. SPAIN ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 32. REST OF EUROPE ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 33. JAPAN ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 34. CHINA ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 35. INDIA ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 36. AUSTRALIA ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 37. SOUTH KOREA ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 38. REST OF ASIA-PACIFIC ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 39. BRAZIL ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 40. SAUDI ARABIA ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 41. SOUTH AFRICA ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 42. REST OF LAMEA ALBUMIN MARKET, 2022-2032 ($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47. COMPETITIVE DASHBOARD
FIGURE 48. COMPETITIVE HEATMAP: ALBUMIN MARKET
FIGURE 49. TOP PLAYER POSITIONING, 2022
FIGURE 50. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
FIGURE 51. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. MERCK KGAA: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. SARTORIUS AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. OCTAPHARMA AG: SALES REVENUE, 2020-2022 ($MILLION)
FIGURE 57. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
FIGURE 58. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 59. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
FIGURE 60. GRIFOLS, S.A.: NET SALES, 2020-2022 ($MILLION)
FIGURE 61. GRIFOLS, S.A.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 62. GRIFOLS, S.A.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 63. CSL: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 64. CSL: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 65. CSL: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 66. TAKEDA PHARMACEUTICAL COMPANY LIMITED: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 67. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE SHARE BY REGION, 2023 (%)

Product Code: A02251

Furthermore, the growth of the albumin market is propelled by the increasing implementation of key strategies among major industry players, including product launches, acquisitions, and agreements. For instance, in September 2020, Sartorius Group, a leading international partner of life science research and the biopharmaceutical industry, announced acquisition of Albumedix Ltd, a leader in the field of recombinant albumin-based solutions. In addition, Grifols, a leading global producer of plasma-derived medicines, announced the launch of its latest albumin portfolio innovation, ALBUTEIN FlexBag (Albumin [Human] U.S.P.) in 5% and 25% concentrations. These strategic moves not only drive innovation but also foster market growth by catering to the evolving needs of the healthcare and biopharmaceutical industries.

In addition, technological advancements are key drivers of the growing albumin market. In the pharmaceutical and biotechnology sectors, continuous innovations in production processes and purification techniques enhance the efficiency and quality of albumin products. Advanced technologies also contribute to the development of novel albumin-based formulations, expanding their applications in drug delivery systems and diagnostics. Precision in manufacturing, purification, and analysis ensures high-quality albumin with minimal impurities, meeting stringent regulatory standards. In addition, technological progress facilitates the exploration of alternative sources for albumin production, addressing supply chain challenges. The synergy between technology and albumin production not only improves existing products but also fosters the creation of cutting-edge solutions, fueling the overall expansion of the albumin market.

The albumin market is segmented on the basis of type, application, sales channel, and region. On the basis of type, the market is categorized into human serum albumin, bovine serum albumin, and recombinant albumin. On the basis of application, it is classified into therapeutics, drug formulation & vaccines, component of media, and others. On the basis of sales channel, it is classified into business to business (B2B) and business to consumer (B2C). On the basis of region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major key players that operate in the global albumin market are Takeda Pharmaceutical Company Limited, Merck KGaA, Sartorius AG, Octapharma AG, Thermo Fisher Scientific Inc., Ventria Bioscience Inc, Grifols, S.A., CSL, China Biologic Products Holdings, Inc, and Lazuline Bio. The players have adopted investment, strategic alliance, product approval, clinical trials, expansion, agreement, and acquisition as the key strategies to expand their product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the albumin market analysis from 2022 to 2032 to identify the prevailing albumin market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the albumin market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global albumin market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Patient/epidemiology data at country, region, global level
Regulatory Guidelines
Additional company profiles with specific to client's interest
Expanded list for Company Profiles
Historic market data
Reimbursement Scenario
SWOT Analysis

Key Market Segments

By Type

Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin

By Application

Therapeutics
Drug Formulation and Vaccines
Component of Media
Other

By Sales Channel

B2C
B2B
- Type
- Pharmaceutical Applications

Type

Non Pharmaceutical Applications

Type

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Octapharma AG
Grifols, S.A.
CSL
Ventria Bioscience Inc.
Lazuline Bio
Takeda Pharmaceutical Company Limited
Sartorius AG
Merck KGaA
Thermo Fisher Scientific Inc.
China Biologic Products Holdings, Inc

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Rise in number of surgical procedures
  - 3.4.1.2. Growing awareness regarding blood donations.
  - 3.4.1.3. Rise in use of plasma derived albumin in drug development
- 3.4.2. Restraints
  - 3.4.2.1. Stringent government regulations
- 3.4.3. Opportunities
  - 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: ALBUMIN MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Human Serum Albumin
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Bovine Serum Albumin
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Recombinant Albumin
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: ALBUMIN MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Therapeutics
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Drug Formulation and Vaccines
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Component of Media
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Other
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: ALBUMIN MARKET, BY SALES CHANNEL

6.1. Overview
- 6.1.1. Market size and forecast
6.2. B2C
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. B2B
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.3.4. B2B Albumin Market by Type
  - 6.3.4.1. Pharmaceutical Applications Albumin Market by Type
  - 6.3.4.2. Non Pharmaceutical Applications Albumin Market by Type

CHAPTER 7: ALBUMIN MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by Sales Channel
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Type
  - 7.2.5.1.2. Market size and forecast, by Application
  - 7.2.5.1.3. Market size and forecast, by Sales Channel
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Type
  - 7.2.5.2.2. Market size and forecast, by Application
  - 7.2.5.2.3. Market size and forecast, by Sales Channel
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Type
  - 7.2.5.3.2. Market size and forecast, by Application
  - 7.2.5.3.3. Market size and forecast, by Sales Channel
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by Sales Channel
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Type
  - 7.3.5.1.2. Market size and forecast, by Application
  - 7.3.5.1.3. Market size and forecast, by Sales Channel
  - 7.3.5.2. France
  - 7.3.5.2.1. Market size and forecast, by Type
  - 7.3.5.2.2. Market size and forecast, by Application
  - 7.3.5.2.3. Market size and forecast, by Sales Channel
  - 7.3.5.3. UK
  - 7.3.5.3.1. Market size and forecast, by Type
  - 7.3.5.3.2. Market size and forecast, by Application
  - 7.3.5.3.3. Market size and forecast, by Sales Channel
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Market size and forecast, by Type
  - 7.3.5.4.2. Market size and forecast, by Application
  - 7.3.5.4.3. Market size and forecast, by Sales Channel
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Market size and forecast, by Type
  - 7.3.5.5.2. Market size and forecast, by Application
  - 7.3.5.5.3. Market size and forecast, by Sales Channel
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Type
  - 7.3.5.6.2. Market size and forecast, by Application
  - 7.3.5.6.3. Market size and forecast, by Sales Channel
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by Sales Channel
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Market size and forecast, by Type
  - 7.4.5.1.2. Market size and forecast, by Application
  - 7.4.5.1.3. Market size and forecast, by Sales Channel
  - 7.4.5.2. China
  - 7.4.5.2.1. Market size and forecast, by Type
  - 7.4.5.2.2. Market size and forecast, by Application
  - 7.4.5.2.3. Market size and forecast, by Sales Channel
  - 7.4.5.3. India
  - 7.4.5.3.1. Market size and forecast, by Type
  - 7.4.5.3.2. Market size and forecast, by Application
  - 7.4.5.3.3. Market size and forecast, by Sales Channel
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Market size and forecast, by Type
  - 7.4.5.4.2. Market size and forecast, by Application
  - 7.4.5.4.3. Market size and forecast, by Sales Channel
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Market size and forecast, by Type
  - 7.4.5.5.2. Market size and forecast, by Application
  - 7.4.5.5.3. Market size and forecast, by Sales Channel
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Market size and forecast, by Type
  - 7.4.5.6.2. Market size and forecast, by Application
  - 7.4.5.6.3. Market size and forecast, by Sales Channel
7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by Sales Channel
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Market size and forecast, by Type
  - 7.5.5.1.2. Market size and forecast, by Application
  - 7.5.5.1.3. Market size and forecast, by Sales Channel
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Market size and forecast, by Type
  - 7.5.5.2.2. Market size and forecast, by Application
  - 7.5.5.2.3. Market size and forecast, by Sales Channel
  - 7.5.5.3. South Africa
  - 7.5.5.3.1. Market size and forecast, by Type
  - 7.5.5.3.2. Market size and forecast, by Application
  - 7.5.5.3.3. Market size and forecast, by Sales Channel
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Market size and forecast, by Type
  - 7.5.5.4.2. Market size and forecast, by Application
  - 7.5.5.4.3. Market size and forecast, by Sales Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Merck KGaA
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
9.2. Sartorius AG
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
9.3. Octapharma AG
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
9.4. Thermo Fisher Scientific Inc.
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
9.5. Ventria Bioscience Inc.
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
9.6. Grifols, S.A.
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
9.7. CSL
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
9.8. China Biologic Products Holdings, Inc
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
9.9. Lazuline Bio
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
9.10. Takeda Pharmaceutical Company Limited
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments

アルブミン市場：タイプ別、用途別、販売チャネル別：世界の機会分析と産業予測、2023-2032年

Albumin Market By Type, By Application, By Sales Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

利害関係者にとっての主なメリット

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章アルブミン市場：タイプ別

第5章アルブミン市場：用途別

第6章アルブミン市場：販売チャネル別

第7章アルブミン市場、地域別

第8章競争情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Type

By Application

By Sales Channel

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: ALBUMIN MARKET, BY TYPE

CHAPTER 5: ALBUMIN MARKET, BY APPLICATION

CHAPTER 6: ALBUMIN MARKET, BY SALES CHANNEL

CHAPTER 7: ALBUMIN MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

アルブミン市場：タイプ別、用途別、販売チャネル別：世界の機会分析と産業予測、2023-2032年

Albumin Market By Type, By Application, By Sales Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

利害関係者にとっての主なメリット

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 アルブミン市場：タイプ別

第5章 アルブミン市場：用途別

第6章 アルブミン市場：販売チャネル別

第7章 アルブミン市場、地域別

第8章 競争情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Type

By Application

By Sales Channel

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: ALBUMIN MARKET, BY TYPE

CHAPTER 5: ALBUMIN MARKET, BY APPLICATION

CHAPTER 6: ALBUMIN MARKET, BY SALES CHANNEL

CHAPTER 7: ALBUMIN MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章アルブミン市場：タイプ別

第5章アルブミン市場：用途別

第6章アルブミン市場：販売チャネル別

第7章アルブミン市場、地域別

第8章競争情勢

第9章企業プロファイル